Vigonvita Life Sciences Co., Ltd. (HKG:2630)

Vigonvita Life Sciences Revenue

Vigonvita Life Sciences had revenue of 65.89M CNY in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 217.26M. In the year 2025, Vigonvita Life Sciences had annual revenue of 102.10M with 762.88% growth. That makes Vigonvita Life Sciences the 30,961st largest company in the world by revenue and 1,855th in Hong Kong.

• Revenue (ttm): 217.26M CNY
• Revenue Growth: +762.88%
• P/S Ratio: 51.32
• Revenue / Employee: 618.98K CNY
• Employees: 351
• Market Cap: 13.15B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• People's Republic of China (PRC) 101.94M 99.8%
• Uzbekistan 156.00K 0.2%

Fiscal year ended Dec 31, 2025 See the full Vigonvita Life Sciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	102.10M	90.26M	762.88%
Dec 31, 2024	11.83M	-187.82M	-94.07%
Dec 31, 2023	199.65M	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error